Evaluation of a Novel Immunoassay for Quantification of C1q for Clinical Diagnostic Use

Objectives: C1q is a valuable biomarker of disease activity in systemic lupus erythematosus (SLE). The “gold standard” assay, rocket immunoelectrophoresis (RIE), is time-consuming, and thus a shift to soluble immune precipitation techniques such as nephelometry has occurred. However, quantification...

Descripción completa

Detalles Bibliográficos
Autores principales: Sandholm, Kerstin, Persson, Barbro, Skattum, Lillemor, Eggertsen, Gösta, Nyman, Dag, Gunnarsson, Iva, Svenungson, Elisabet, Nilsson, Bo, Ekdahl, Kristina N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6357986/
https://www.ncbi.nlm.nih.gov/pubmed/30740097
http://dx.doi.org/10.3389/fimmu.2019.00007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6357986/
https://www.ncbi.nlm.nih.gov/pubmed/30740097
http://dx.doi.org/10.3389/fimmu.2019.00007

Ejemplares similares